ABL1 and melanoma: In contrast, other long-term MEKi acquired resistance cells were highly dependent solely on ABL1/2, which stabilized MYC and ETS1 proteins in an ERK-independent manner, and induced β-catenin nuclear localization to drive melanoma survival (Figure 8).